Researcher from the Monash Institute of Pharmaceutical Sciences elected to the Australian National Academy of Science
Professor Thomas Davis has been elected as a Fellow of The Australian National Academy of Science. Professor Davis is an internationally renowned polymer chemist and nanotechnologist.
World-leading pharmaceutical sciences researcher Professor Chris Porter has been appointed Director of the Monash Institute of Pharmaceutical Sciences (MIPS), effective from 3 April 2017.
A coalition of researchers from Monash University, the University of Melbourne and The Indian Institute of Chemical Biology has been awarded A$1 million in research funding to develop a new treatment for the disease Leishmaniasis.
In a paper published today in the influential journal Nature, researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University discuss the use of a novel technique to reveal the structure of an important drug target.
The Monash University Institute of Pharmaceutical Sciences (MIPS) today announced positive results from a first-in-human study of a new, inhaled form of a medicine that could significantly reduce maternal deaths around the world.
The image of an unhealthy person chowing down on a burger and fries one minute then gobbling anti-cholesterol medication in the hope of atoning for their dietary sins is staple of popular culture. But a new study from Monash University researchers
Professor Arthur Christopoulos has been honoured with the British Pharmacological Society ’s prestigious Gaddum Memorial Award. " /. MIPS’ Professor Arthur Christopoulos has been honoured with the British Pharmacological Society ’s prestigious
A/Prof Michelle McIntosh has been jointly awarded the Dr John Dixon Hughes Medal for Medical Research Innovation, alongside Prof. Mark Kendall from the University of Queensland, by the National Foundation for Medical Research and Innovation (NFMRI).